Julianne Bruno Crispr Therapeutics Ag (CRSP) insider trading activity
Julianne Bruno is Chief Operating Officer of CRISPR Therapeutics AG. Currently has a direct ownership of 10,544 shares of CRSP, which is worth approximately $358,812. The most recent transaction as insider was on Mar 21, 2025, when has been sold 1,714 shares (Common Shares) at a price of $41.23 per share, resulting in proceeds of $70,668. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
10.5K
56.32%
3M change
n/a
12M change
Total Value Held
$358,812
Julianne Bruno Transaction History
JB
Julianne Bruno
Chief Operating Officer
Boston, MA